Sure hope it’s phase 3 topline data? And that it’s good! Hehehe
$COSCIENS Biopharma (CSCI.US)$ Phase 3 DETECT-Trial For Macimorelin In Diagnosing Childhood Onset Growth Hormone Deficiency is due out Q3 2024
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
